Clinical library

Every tool, one focused workspace.

1,329 calculators and references across 60 specialties, with formula confidence shown up front.

Interactive worksheet

VALIANT Heart Failure (LV Dysfunction) Index Calculator

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction — VALIANT Study: Explanation and clinical context The VALIANT Heart Failure Risk Score was derived from the VALsartan In Acute myocardial iNfarction Trial (VALIANT) cohort and was designed to estimate the risk of first hospitalizati

Interactive worksheet

VALID-CHF Prognostic Model (CardioWebdr)

VALID-CHF Prognostic Model — Explanation and Clinical Context This page implements a configurable template for the VALID-CHF prognostic model. The final prognostic estimate requires the original VALID-CHF model specification (either logistic regression coefficients or a validated point table). At present the template is prepared so you can paste model coefficients into the PHP array near the top of the file and the s

Interactive worksheet

VERTIS-CV Event Prediction (WATCH-DM surrogate) Calculator

VERTIS-CV Event Prediction — implementation notes and clinical context (WATCH-DM surrogate) This tool calculates the integer WATCH-DM score (an externally published, integer-based risk score developed to predict 5-year incident heart-failure hospitalization among patients with type 2 diabetes). WATCH-DM combines routinely available clinical measures (age, BMI, blood pressure), simple blood tests (fasting plasma gluco

Interactive worksheet

VOYAGER-PAD Risk Reduction Index Calculator

VOYAGER-PAD Risk Reduction Index: Explanation and Clinical Context The VOYAGER-PAD Risk Reduction Index is a tool derived from the VOYAGER‑PAD Trial dataset, designed to estimate the three-year probability of a composite outcome (acute limb ischemia, major vascular amputation, myocardial infarction, ischemic stroke, or cardiovascular death) among patients undergoing lower-extremity revascularization for symptomatic p